证券记录 · 已归档季度
MLAB
Mesa Laboratories, Inc. · Healthcare · Medical - Specialties
17被追踪持有人
+1Δ持有人
1.54M持有股份
$103.48M报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +6.2% ·
股份流向 -24.3% ·
净新建仓位 +5.9%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 67 | 0 | 2.99M | $297.50M | +4 | −4 |
| Q1 2026 | 70 | 0 | 2.66M | $235.21M | +6 | −6 |
| Q4 2025 | 70 | +2 | 2.73M | $214.06M | +2 | — |
| Q3 2025 | 17 | +1 | 1.54M | $103.48M | +2 | −1 |
| Q2 2025 | 13 | +4 | 1.73M | $163.31M | +4 | — |
| Q1 2025 | 6 | -3 | 383.09K | $45.46M | — | −3 |
| Q4 2024 | 9 | +1 | 400.64K | $52.84M | +1 | — |
| Q3 2024 | 7 | 0 | 174.94K | $22.72M | +1 | −1 |
| Q2 2024 | 7 | — | 189.52K | $16.45M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (被动) | 321.72K | -17.4% | $21.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (被动) | 321.72K | -17.4% | $21.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (被动) | 321.72K | -17.4% | $21.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Millennium Management ✦ | 133.82K | +131.9% | $8.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | Geode Capital Management ✦ (被动) | 127.86K | -7.9% | $8.57M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 25 | Geode Capital Management ✦ (被动) | 127.86K | -7.9% | $8.57M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 26 | State Street Global Advisors ✦ (被动) | 118.95K | -43.9% | $7.97M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 27 | Goldman Sachs Group ✦ | 41.78K | — | $2.80M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Goldman Sachs Group ✦ | 41.78K | — | $2.80M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 34.18K | +27.2% | $2.29M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 30 | Citadel Advisors ✦ | 34.18K | +27.2% | $2.29M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 32.81K | +278.7% | $2.20M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 32.64K | +322.4% | $2.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 32.64K | +322.4% | $2.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 32.64K | +322.4% | $2.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 32.64K | +322.4% | $2.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 32.64K | +322.4% | $2.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 37 | Marshall Wace ✦ | 14.60K | 新增 | $978,346 | 0.0% | New | 1 | SEC ↗ |
| 38 | Marshall Wace ✦ | 14.60K | 新增 | $978,346 | 0.0% | New | 1 | SEC ↗ |
| 39 | Marshall Wace ✦ | 14.60K | 新增 | $978,346 | 0.0% | New | 1 | SEC ↗ |
| 40 | Renaissance Technologies ✦ | 10.90K | -84.0% | $730,409 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 41 | Two Sigma Investments ✦ | 9.62K | 新增 | $644,837 | 0.0% | New | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 50 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 51 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 52 | GAMCO Investors ✦ | 8.21K | +109.0% | $550,286 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 53 | T. Rowe Price ✦ | 4.11K | +7.4% | $276,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 54 | Fidelity (FMR) ✦ | 606 | -79.3% | $40,608 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 55 | Fidelity (FMR) ✦ | 606 | -79.3% | $40,608 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $978,346 | 0.0% |
| Marshall Wace | $978,346 | 0.0% |
| Marshall Wace | $978,346 | 0.0% |
| Two Sigma Investments | $644,837 | 0.0% |
已清仓
| Wellington Management | $2.12M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 158 持有人, 4.82M 股份, $424.86M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Aug 13
Kadia Siddhartha
Officer · President and CEO · 7.09K 股 @ 112.80 · $800,090
Aug 13
Tripeny R Tony
Director · 900 股 @ 113.69 · $102,321
公开市场卖出 (S)
Aug 13
Sullivan John James
Director · 7.09K 股 · $800,090
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jul 07
SC 13G/A — Long Path Smaller Companies Fund, LP
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据